These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 33726886)

  • 21. Helicobacter pylori Infection and Risk of Gastric Cancer in Korea: A Quantitative Systematic Review.
    Bae JM; Kim EH
    J Prev Med Public Health; 2016 Jul; 49(4):197-204. PubMed ID: 27499162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of Serum Pepsinogen II and
    Baek SM; Kim N; Kwon YJ; Lee HS; Kim HY; Lee J; Yoon H; Shin CM; Park YS; Lee DH
    Gut Liver; 2020 Jul; 14(4):439-449. PubMed ID: 31533397
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence of and risk factors for metachronous gastric cancer after endoscopic resection and successful Helicobacter pylori eradication: results of a large-scale, multicenter cohort study in Japan.
    Mori G; Nakajima T; Asada K; Shimazu T; Yamamichi N; Maekita T; Yokoi C; Fujishiro M; Gotoda T; Ichinose M; Ushijima T; Oda I
    Gastric Cancer; 2016 Jul; 19(3):911-8. PubMed ID: 26420267
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The association between Helicobacter pylori status and incidence of metachronous gastric cancer after endoscopic resection of early gastric cancer.
    Kim YI; Choi IJ; Kook MC; Cho SJ; Lee JY; Kim CG; Ryu KW; Kim YW
    Helicobacter; 2014 Jun; 19(3):194-201. PubMed ID: 24612125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [What's new in cancer of the stomach? An overview of the literature of this year].
    Perrot L; Champault G
    J Chir (Paris); 1998 Oct; 135(4):148-54. PubMed ID: 9827393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the Clinicopathological Characteristics and Genetic Alterations Between Patients with Gastric Cancer with or Without
    Fang WL; Huang KH; Chang SC; Lin CH; Chen MH; Chao Y; Lo SS; Li AF; Wu CW; Shyr YM
    Oncologist; 2019 Sep; 24(9):e845-e853. PubMed ID: 30796154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic alterations in gastric cancer: relation to histological subtypes, tumor stage, and Helicobacter pylori infection.
    Wu MS; Shun CT; Wang HP; Sheu JC; Lee WJ; Wang TH; Lin JT
    Gastroenterology; 1997 May; 112(5):1457-65. PubMed ID: 9136822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gastric cancer: new genetic developments.
    Lynch HT; Grady W; Suriano G; Huntsman D
    J Surg Oncol; 2005 Jun; 90(3):114-33; discussion 133. PubMed ID: 15895459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular classification of gastric cancer.
    Röcken C
    Expert Rev Mol Diagn; 2017 Mar; 17(3):293-301. PubMed ID: 28118758
    [TBL] [Abstract][Full Text] [Related]  

  • 30. After Helicobacter pylori, genetic susceptibility to gastric carcinoma revisited.
    Canedo P; Figueiredo C; Machado JC
    Helicobacter; 2007 Nov; 12 Suppl 2():45-9. PubMed ID: 17991176
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gastric cancer: epidemiology, prevention, and therapy.
    Venerito M; Vasapolli R; Rokkas T; Malfertheiner P
    Helicobacter; 2018 Sep; 23 Suppl 1():e12518. PubMed ID: 30203589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening of gastric cancer: who, when, and how.
    Lin JT
    Clin Gastroenterol Hepatol; 2014 Jan; 12(1):135-8. PubMed ID: 24107396
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular identification of main cellular lineages as a tool for the classification of gastric cancer.
    Sepulveda AR; Wu L; Ota H; Gutierrez O; Kim JG; Genta RM; Graham DY
    Hum Pathol; 2000 May; 31(5):566-74. PubMed ID: 10836295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Infections and epigenetic changes in cancer].
    Corvalán AH; Maturana MJ
    Rev Chil Pediatr; 2016; 87(4):245-9. PubMed ID: 27474231
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Screening of gastric cancer in Asia.
    Sugano K
    Best Pract Res Clin Gastroenterol; 2015 Dec; 29(6):895-905. PubMed ID: 26651251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heterogeneity in Gastric Cancer: From Pure Morphology to Molecular Classifications.
    Gullo I; Carneiro F; Oliveira C; Almeida GM
    Pathobiology; 2018; 85(1-2):50-63. PubMed ID: 28618420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening and eradication of
    Liou JM; Malfertheiner P; Lee YC; Sheu BS; Sugano K; Cheng HC; Yeoh KG; Hsu PI; Goh KL; Mahachai V; Gotoda T; Chang WL; Chen MJ; Chiang TH; Chen CC; Wu CY; Leow AH; Wu JY; Wu DC; Hong TC; Lu H; Yamaoka Y; Megraud F; Chan FKL; Sung JJ; Lin JT; Graham DY; Wu MS; El-Omar EM;
    Gut; 2020 Dec; 69(12):2093-2112. PubMed ID: 33004546
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship of p53 and c-erbB-2 expression to histopathological features, Helicobacter pylori infection and prognosis in gastric cancer.
    Shun CT; Wu MS; Lin JT; Chen SY; Wang HP; Lee WJ; Wang TH; Chuang SM
    Hepatogastroenterology; 1997; 44(14):604-9. PubMed ID: 9164544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Three-year interval for endoscopic screening may reduce the mortality in patients with gastric cancer.
    Choi SI; Park B; Joo J; Kim YI; Lee JY; Kim CG; Choi IJ; Kook MC; Cho SJ
    Surg Endosc; 2019 Mar; 33(3):861-869. PubMed ID: 30006847
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between
    de Souza CRT; Almeida MCA; Khayat AS; da Silva EL; Soares PC; Chaves LC; Burbano RMR
    World J Gastroenterol; 2018 Nov; 24(43):4928-4938. PubMed ID: 30487702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.